£515.00

The 2023-2028 Outlook for Pseudotumor Cerebri in India

Price data last checked 85 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 6 days • 6 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 26 January 2026 27 January 2026 28 January 2026 29 January 2026 31 January 2026

Price Distribution

Price distribution over 6 days • 1 price levels

Days at Price
6 days 0 2 3 5 6 £515 Days at Price

Price Analysis

Most common price: £515 (6 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 6 days

Product Specifications
Format
paperback
ASIN
B0BGKTG725
Category
Books > Subjects
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States
98% match

The 2023-2028 Outlook for Pseudotumor Cerebri in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 24 Feb 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
97% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
97% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

£515.00 06 Feb 2026
The 2023-2028 World Outlook for Pseudotumor Cerebri
97% match

The 2023-2028 World Outlook for Pseudotumor Cerebri

Out of Stock 09 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Vision Care in India
96% match

The 2023-2028 Outlook for Vision Care in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Neurostimulation Devices in India
96% match

The 2023-2028 Outlook for Neurostimulation Devices in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for External Neurostimulation in India
96% match

The 2023-2028 Outlook for External Neurostimulation in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India
96% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Uveitis Drugs in India
96% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in India
96% match

The 2023-2028 Outlook for Macular Degeneration Treatments in India

£515.00 29 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Diabetic Neuropathy in India
96% match

The 2023-2028 Outlook for Diabetic Neuropathy in India

£515.00 13 Jan 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in India
96% match

The 2023-2028 Outlook for Anti-Migraine Drugs in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in India
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Diabetic Ulcers in India
96% match

The 2023-2028 Outlook for Diabetic Ulcers in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in India
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Epilepsy Monitoring Devices in India
96% match

The 2023-2028 Outlook for Epilepsy Monitoring Devices in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
96% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

£515.00 11 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India

£515.00 31 Jan 2026